| Q38748975 | Clinical determinants of calcineurin inhibitor disposition: a mechanistic review |
| Q36725218 | Clinical relevance of the small intestine as an organ of drug elimination: drug-fruit juice interactions. |
| Q37658866 | Clinically based evidence of drug-herb interactions: a systematic review |
| Q38591894 | Cranberry Products for the Prophylaxis of Urinary Tract Infections in Pediatric Patients |
| Q34980947 | Cranberry and urinary tract infections |
| Q36912863 | Cranberry juice-- a well-characterized folk-remedy against bacterial urinary tract infection |
| Q37526981 | Dietary regulation of P-gp function and expression |
| Q36956314 | Dietary supplements, herbs and oral anticoagulants: the nature of the evidence |
| Q37054184 | Effect of cranberry dietary supplements with different brands on human CYP3A4 enzyme |
| Q46496890 | Effect of food on systemic exposure to niflumic acid following postprandial administration of talniflumate |
| Q41733187 | Effect of standardized cranberry extract on the activity and expression of selected biotransformation enzymes in rat liver and intestine. |
| Q43065637 | Effects of Nigella sativa and Lepidium sativum on cyclosporine pharmacokinetics |
| Q48610637 | Effects of daily ingestion of cranberry juice on the pharmacokinetics of warfarin, tizanidine, and midazolam--probes of CYP2C9, CYP1A2, and CYP3A4. |
| Q37395763 | Effects of dietary factors on drug transport and metabolism: the impact on dosage guidelines in transplant patients |
| Q89909661 | Effects of tomato juice on the pharmacokinetics of CYP3A4-substrate drugs |
| Q37808478 | Herb-drug pharmacokinetic interactions reviewed. |
| Q37116195 | Identification of a cranberry juice product that inhibits enteric CYP3A-mediated first-pass metabolism in humans. |
| Q46709627 | In vitro inhibition of CYP3A4 metabolism and P-glycoprotein-mediated transport by trade herbal products |
| Q45808951 | In vitro inhibition of human CYP1A2, CYP2D6, and CYP3A4 by six herbs commonly used in pregnancy |
| Q34553835 | Influence of dietary substances on intestinal drug metabolism and transport. |
| Q38866934 | Influence of grapefruit juice on pharmacokinetics of triptolide in rats grapefruit juice on the effects of triptolide |
| Q34562224 | Interaction between warfarin and cranberry juice |
| Q38859562 | Interaction of Citrus Juices with Cyclosporine: Systematic Review and Meta-Analysis. |
| Q36745175 | Interaction potential between cranberry juice and warfarin |
| Q34124444 | Interactions between herbs and conventional drugs: overview of the clinical data. |
| Q50454323 | Is a flavonoid-rich diet with steamer cooking safe during calcineurin inhibitors therapy? |
| Q34504635 | Isolation and identification of intestinal CYP3A inhibitors from cranberry (Vaccinium macrocarpon) using human intestinal microsomes. |
| Q36842490 | Pharmacodynamic interaction of warfarin with cranberry but not with garlic in healthy subjects |
| Q42693981 | Pomelo enhances cyclosporine bioavailability in healthy male Thai volunteers |
| Q37118021 | Review article: cytochrome P450 enzyme, and transport protein mediated herb-drug interactions in renal transplant patients: grapefruit juice, St John's Wort - and beyond! |
| Q47159391 | Safety of cranberry extract powder as a novel food ingredient pursuant to Regulation (EC) No 258/97 |
| Q43261108 | The effects of pummelo juice on pharmacokinetics of sildenafil in healthy adult male Jordanian volunteers. |
| Q37107850 | Urinary tract infection in the renal transplant patient |